跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,270 条关于
“Pivotal bioVenture Partners”
全部
10,270
临床试验
1,616
药物
23
机构
47
资讯
8,584
去年
Mosanna Therapeutics Secures $80M Series A to Advance Nasal Spray Treatment for Obstructive Sleep Apnea
去年
Windward Bio Secures Global License for Anti-TSLP Antibody SKB378/HBM9378 in $970M Deal
去年
Windward Bio Launches with $200 Million to Advance Long-Acting Anti-TSLP Antibody for Asthma and COPD
10个月前
Cybin Closes $175 Million Financing to Advance Phase 3 Psychedelic Depression Treatment
11个月前
Evommune Files for $100M IPO to Advance Novel MRGPRX2-Targeting Drug for Chronic Urticaria
4个月前
Windward Bio Secures $165M to Advance Ultra Long-Acting Immunology Therapies for Asthma and COPD
去年
Paradigm Partners with Advanced Clinical for Pivotal Phase III Osteoarthritis Trial
3个月前
Claret Capital Partners Commits €43M to Inventiva's €130M Financing for Pivotal MASH Phase 3 Trial
去年
Novo’s CagriSema Disappoints in Pivotal Trial
11个月前
Asabys Partners Integrates Aliath Bioventures in €468M Strategic Consolidation to Build €1B Life Sciences Platform
第 1 页,共 859 页
上一页
下一页